EUVIMEDEUVIMED entdecken
Crossref

Employing Late-Stage Functionalization Strategies to Address Metabolic Challenges in Drug Discovery

Kevin D. Dykstra, Amy B. McCracken, Melodie M. Christensen, Cheol K. Chung, Daniel DiRocco, George Doss, Kerry Fillgrove, David Hesk, Scott B. Hoyt, Claire Lankin, Derun Li, Guoqing Li und 12 weitere

Synlett · 03.11.2026

DOI: 10.1055/a-2981-3437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synlett, online erschienen am 03.11.2026. Verfasst von Kevin D. Dykstra und 23 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the course of medicinal chemistry campaigns, issues related to drug metabolism frequently present significant challenges to progressing chemical series toward tool molecules or clinical candidates. Addressing these issues typically requires designing molecules with specific point changes to test particular metabolism-related hypotheses. However, accessing these test molecules in a timely manner to inform future rounds of decision-making and design often presents a significant synthetic challenge. In this report, we present case studies showcasing the use of Minsici and direct metalation chemistries as part of a late-stage functionalization strategy to address specific metabolic issues plaguing two medicinal chemistry programs. The success of these approaches allowed rapid access to new analogs with improved metabolic stability, and more importantly, key insights that informed on strategies to progress these chemical series toward valuable tool compounds.

Zitieren

APA

Dykstra, K. D., McCracken, A. B., Christensen, M. M., Chung, C. K., DiRocco, D., Doss, G., Fillgrove, K., Hesk, D., Hoyt, S. B., Lankin, C., Li, D., Li, G., Liu, Y., McKittrick, B., Reibarkh, M., Small, J., Streckfuss, E., Taoka, B., Walsh, S., …, & Vachal, P. (2026). Employing Late-Stage Functionalization Strategies to Address Metabolic Challenges in Drug Discovery. Synlett. https://doi.org/10.1055/a-2981-3437

Vancouver

Dykstra KD, McCracken AB, Christensen MM, Chung CK, DiRocco D, Doss G, et al. Employing Late-Stage Functionalization Strategies to Address Metabolic Challenges in Drug Discovery. Synlett. 2026. doi:10.1055/a-2981-3437

BibTeX
@article{Dykstra2026,
  author = {Dykstra, Kevin D. and McCracken, Amy B. and Christensen, Melodie M. and Chung, Cheol K. and DiRocco, Daniel and Doss, George and Fillgrove, Kerry and Hesk, David and Hoyt, Scott B. and Lankin, Claire and Li, Derun and Li, Guoqing and Liu, Yong and McKittrick, Brian and Reibarkh, Mikhail and Small, James and Streckfuss, Eric and Taoka, Brandon and Walsh, Shawn and Xiao, Li and Yao, Huifang and Zhong, Wendy and Krska, Shane W. and Vachal, Petr},
  title = {Employing Late-Stage Functionalization Strategies to Address Metabolic Challenges in Drug Discovery},
  journal = {Synlett},
  year = {2026},
  doi = {10.1055/a-2981-3437}
}
Kostenlos starten →